{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:02:20Z","timestamp":1776132140681,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00277-018-3462-y","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:02:29Z","timestamp":1536537749000},"page":"2319-2324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A monocentric retrospective study of 138 therapy-related myeloid neoplasms"],"prefix":"10.1007","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9637-5592","authenticated-orcid":false,"given":"Helena","family":"Claerhout","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"Lierman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucienne","family":"Michaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Boeckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"3462_CR1","unstructured":"Vardiman JW, Arber DA, Brunning RD, Larson RA, Matutes E, Baumann I et al (2017) Therapy-related myeloid neoplasms. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency of Research on Cancer (IARC), Lyon, p 153\u2013155"},{"key":"3462_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1309\/AJCPU1JO2LYTWUAV","volume":"144","author":"CE Bueso-Ramos","year":"2015","unstructured":"Bueso-Ramos CE, Kanagal-Shamanna R, Routbort MJ, Hanson CA (2015) Therapy-related myeloid neoplasms. Am J Clin Pathol 144:207\u2013218","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"3462_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrc.2017.60","volume":"17","author":"ME McNerney","year":"2017","unstructured":"McNerney ME, Godley LA, Le Beau MM (2017) Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer 17(9):513\u2013527","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3462_CR4","doi-asserted-by":"publisher","first-page":"E80","DOI":"10.1002\/ajh.23966","volume":"90","author":"L Fianchi","year":"2015","unstructured":"Fianchi L, Pagano L, Piciocchi A, Candoni A, Gaidano G, Breccia M, Criscuolo M, Specchia G, Maria Pogliani E, Maurillo L, Aloe-Spiriti MA, Mecucci C, Niscola P, Rossetti E, Mansueto G, Rondoni M, Fozza C, Invernizzi R, Spadea A, Fenu S, Buda G, Gobbi M, Fabiani E, Sica S, Hohaus S, Leone G, Voso MT (2015) Characteristics and outcome of therapy-related myeloid neoplasms: report from the Italian network on secondary leukemias. Am J Hematol 90(5):E80\u2013E85","journal-title":"Am J Hematol"},{"key":"3462_CR5","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3109\/10428194.2014.946023","volume":"56","author":"Y Chen","year":"2015","unstructured":"Chen Y, Estrov Z, Pierce S, Qiao W, Borthakur G, Ravandi F, Kadia T, Brandt M, O\u2019Brien S, Jabbour E, Garcia-Manero G, Cortes J, Beran M (2015) Myeloid neoplasms after breast cancer: \u201ctherapy-related\u201d not an independent poor prognostic factor. Leuk Lymphoma 56:1012\u20131019","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"3462_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3324\/haematol.2008.000927","volume":"94","author":"N Kr\u00f6ger","year":"2009","unstructured":"Kr\u00f6ger N, Brand R, Van Biezen A, Zander A, Dierlamm J, Niederwieser D et al (2009) Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation. Haematologica 94(4):542\u2013549","journal-title":"Haematologica"},{"issue":"2","key":"3462_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.clml.2014.07.001","volume":"15","author":"N Pemmaraju","year":"2015","unstructured":"Pemmaraju N, Shah D, Kantarjian H, Orlowski RZ, Nogueras Gonz\u00e1lez GM, Baladandayuthapani V, Jain N, Wagner V, Garcia-Manero G, Shah J, Ravandi F, Pierce S, Takahashi K, Daver N, Nazha A, Verstovsek S, Jabbour E, de Lima M, Champlin R, Cortes J, Qazilbash MH (2015) Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia. Clin Lymphoma, Myeloma Leuk 15(2):110\u2013114","journal-title":"Clin Lymphoma, Myeloma Leuk"},{"issue":"6","key":"3462_CR8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3324\/haematol.2012.076729","volume":"98","author":"AH Shih","year":"2013","unstructured":"Shih AH, Chung SS, Dolezal EK, Zhang S-J, Abdel-Wahab OI, Park CY, Nimer SD, Levine RL, Klimek VM (2013) Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia. Haematologica 98(6):908\u2013912","journal-title":"Haematologica"},{"issue":"2","key":"3462_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/cncr.29615","volume":"122","author":"JE Churpek","year":"2016","unstructured":"Churpek JE, Marquez R, Neistadt B, Claussen K, Lee MK, Churpek MM, Huo D, Weiner H, Bannerjee M, Godley LA, le Beau MM, Pritchard CC, Walsh T, King MC, Olopade OI, Larson RA (2016) Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia. Cancer 122(2):304\u2013311","journal-title":"Cancer"},{"issue":"15","key":"3462_CR10","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1182\/blood-2012-08-448068","volume":"121","author":"LM Morton","year":"2013","unstructured":"Morton LM, Dores GM, Tucker MA, Kim CJ, Onel K, Gilbert ES, Fraumeni JF, Curtis RE (2013) Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood 121(15):2996\u20133004","journal-title":"Blood"},{"issue":"1","key":"3462_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","volume":"102","author":"SM Smith","year":"2003","unstructured":"Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J et al (2003) Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 102(1):43\u201352","journal-title":"Blood"},{"issue":"2","key":"3462_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/leu.2015.258","volume":"30","author":"T Radivoyevitch","year":"2016","unstructured":"Radivoyevitch T, Sachs RK, Gale RP, Molenaar RJ, Brenner DJ, Hill BT, Kalaycio ME, Carraway HE, Mukherjee S, Sekeres MA, Maciejewski JP (2016) Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation. Leukemia 30(2):285\u2013294","journal-title":"Leukemia"},{"key":"3462_CR13","unstructured":"Henau K, Francart J, Silversmit G, Vandendael T, Pieters G, Xicluna J et al (2015) Cancer burden in Belgium. Belgian Cancer Registry, Brussels, p 135\u2013146"},{"issue":"4","key":"3462_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.beha.2013.09.001","volume":"26","author":"JE Churpek","year":"2013","unstructured":"Churpek JE, Larson RA (2013) The evolving challenge of therapy-related myeloid neoplasms. Best Pract Res Clin Haematol 26(4):309\u2013317","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"3462_CR15","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/j.1476-5381.2010.01100.x","volume":"162","author":"H Sill","year":"2011","unstructured":"Sill H, Olipitz W, Zebisch A, Schulz E, W\u00f6lfler A (2011) Therapy-related myeloid neoplasms: pathobiology and clinical characteristics. Br J Pharmacol 162(4):792\u2013805","journal-title":"Br J Pharmacol"},{"issue":"2","key":"3462_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/sj.leu.2405078","volume":"22","author":"J Pedersen-Bjergaard","year":"2008","unstructured":"Pedersen-Bjergaard J, Andersen MK, Andersen MT, Christiansen DH (2008) Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 22(2):240\u2013248","journal-title":"Leukemia"},{"issue":"7540","key":"3462_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature13968","volume":"518","author":"TN Wong","year":"2015","unstructured":"Wong TN, Ramsingh G, Young AL, Miller CA, Touma W, Welch JS, Lamprecht TL, Shen D, Hundal J, Fulton RS, Heath S, Baty JD, Klco JM, Ding L, Mardis ER, Westervelt P, DiPersio JF, Walter MJ, Graubert TA, Ley TJ, Druley TE, Link DC, Wilson RK (2015) Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature 518(7540):552\u2013555","journal-title":"Nature"},{"issue":"7","key":"3462_CR18","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1182\/blood-2010-08-301713","volume":"117","author":"S Kayser","year":"2011","unstructured":"Kayser S, D\u00f6hner K, Krauter J, K\u00f6hne CH, Horst HA, Held G et al (2011) Impact of therapy-related acute myeloid leukaemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood 117(7):2137\u20132145","journal-title":"Blood"},{"issue":"12","key":"3462_CR19","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1200\/JCO.2004.99.301","volume":"22","author":"W Kern","year":"2004","unstructured":"Kern W (2004) Prognosis in therapy-related acute myeloid leukemia and impact of karyotype. J Clin Oncol 22(12):2510\u20132511","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3462-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3462-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3462-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T19:06:22Z","timestamp":1568055982000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3462-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3462"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3462-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"23 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}